These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350 [TBL] [Abstract][Full Text] [Related]
3. Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia. Jensen PØ; Moser C; Kharazmi A; Presler T; Koch C; Høiby N J Cyst Fibros; 2006 Aug; 5(3):145-51. PubMed ID: 16503423 [TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. Kronborg G APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607 [TBL] [Abstract][Full Text] [Related]
6. Pan-Resistant Achromobacter xylosoxidans and Stenotrophomonas maltophilia Infection in Cystic Fibrosis Does Not Reduce Survival After Lung Transplantation. Lobo LJ; Tulu Z; Aris RM; Noone PG Transplantation; 2015 Oct; 99(10):2196-202. PubMed ID: 25856407 [TBL] [Abstract][Full Text] [Related]
7. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy. Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808 [TBL] [Abstract][Full Text] [Related]
8. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections. Bodini A; D'Orazio C; Peroni D; Corradi M; Folesani G; Baraldi E; Assael BM; Boner A; Piacentini GL Pediatr Pulmonol; 2005 Dec; 40(6):494-9. PubMed ID: 16229003 [TBL] [Abstract][Full Text] [Related]
9. Achromobacter xylosoxidans infection in an adult cystic fibrosis unit in Madrid. Llorca Otero L; Girón Moreno R; Buendía Moreno B; Valenzuela C; Guiu Martínez A; Alarcón Cavero T Enferm Infecc Microbiol Clin; 2016 Mar; 34(3):184-7. PubMed ID: 26139304 [TBL] [Abstract][Full Text] [Related]
10. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum. Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256 [TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571 [TBL] [Abstract][Full Text] [Related]
12. Predictors of mortality in adults with cystic fibrosis. Courtney JM; Bradley J; Mccaughan J; O'Connor TM; Shortt C; Bredin CP; Bradbury I; Elborn JS Pediatr Pulmonol; 2007 Jun; 42(6):525-32. PubMed ID: 17469153 [TBL] [Abstract][Full Text] [Related]
13. A heat-stable cytotoxic factor produced by Achromobacter xylosoxidans isolated from Brazilian patients with CF is associated with in vitro increased proinflammatory cytokines. Mantovani RP; Levy CE; Yano T J Cyst Fibros; 2012 Jul; 11(4):305-11. PubMed ID: 22440828 [TBL] [Abstract][Full Text] [Related]
14. Emerging and unusual gram-negative infections in cystic fibrosis. Davies JC; Rubin BK Semin Respir Crit Care Med; 2007 Jun; 28(3):312-21. PubMed ID: 17562501 [TBL] [Abstract][Full Text] [Related]
15. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. Courtney JM; Dunbar KE; McDowell A; Moore JE; Warke TJ; Stevenson M; Elborn JS J Cyst Fibros; 2004 Jun; 3(2):93-8. PubMed ID: 15463892 [TBL] [Abstract][Full Text] [Related]
17. Neutrophil cell death, activation and bacterial infection in cystic fibrosis. Watt AP; Courtney J; Moore J; Ennis M; Elborn JS Thorax; 2005 Aug; 60(8):659-64. PubMed ID: 16061707 [TBL] [Abstract][Full Text] [Related]
18. Differential cytokine profile in children with cystic fibrosis. Brazova J; Sediva A; Pospisilova D; Vavrova V; Pohunek P; Macek M; Bartunkova J; Lauschmann H Clin Immunol; 2005 May; 115(2):210-5. PubMed ID: 15885645 [TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. Moser C; Jensen PØ; Pressler T; Frederiksen B; Lanng S; Kharazmi A; Koch C; Høiby N APMIS; 2005 Jun; 113(6):400-9. PubMed ID: 15996157 [TBL] [Abstract][Full Text] [Related]
20. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. Rønne Hansen C; Pressler T; Høiby N; Gormsen M J Cyst Fibros; 2006 Dec; 5(4):245-51. PubMed ID: 16777495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]